Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma

por Venugopal, Balaji, Ansari, Jawaher, Aitchison, Michael, Tho, Lye Mun, Campbell, Roderick, Jones, Rob J
Publicado 2013

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

por Brown, Sarah D., Nativo, Paola, Smith, Jo-Ann, Stirling, David, Edwards, Paul R., Venugopal, Balaji, Flint, David J., Plumb, Jane A., Graham, Duncan, Wheate, Nial J.
Publicado 2010

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

por Cook, Natalie, Basu, Bristi, Smith, Donna-Michelle, Gopinathan, Aarthi, Evans, Jeffry, Steward, William P, Palmer, Daniel, Propper, David, Venugopal, Balaji, Hategan, Mirela, Anthoney, D Alan, Hampson, Lisa V, Nebozhyn, Michael, Tuveson, David, Farmer-Hall, Hayley, Turner, Helen, McLeod, Robert, Halford, Sarah, Jodrell, Duncan
Publicado en Br J Cancer (2018)

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

por Motzer, Robert J., Penkov, Konstantin, Haanen, John, Rini, Brian, Albiges, Laurence, Campbell, Matthew T., Venugopal, Balaji, Kollmannsberger, Christian, Negrier, Sylvie, Uemura, Motohide, Lee, Jae L., Vasiliev, Aleksandr, Miller, Wilson H., Gurney, Howard, Schmidinger, Manuela, Larkin, James, Atkins, Michael B., Bedke, Jens, Alekseev, Boris, Wang, Jing, Mariani, Mariangela, Robbins, Paul B., Chudnovsky, Aleksander, Fowst, Camilla, Hariharan, Subramanian, Huang, Bo, di Pietro, Alessandra, Choueiri, Toni K.
Publicado en N Engl J Med (2019)